Drug- and mutagenesis-induced changes in the selectivity filter of a cardiac two-pore background K+ channel

Cardiovascular Research

Volumn 58, Issue 1, 2003, Pages 46-54

  Hajdú, Péter ^a   Ulens, Chris ^b   Panyi, György ^a   Tytgat, Jan ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Ion channels; K channel; Membrane currents; Membrane permeability physics; Myocytes

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; DEXTRO NORPROPOXYPHENE; FLUOXETINE; POTASSIUM CHANNEL; POTASSIUM ION; PROTEIN; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MICROELECTRODE; MUTAGENESIS; NONHUMAN; OOCYTE; PERMEABILITY; PHENOTYPE; POINT MUTATION; POROSITY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VOLTAGE CLAMP; XENOPUS LAEVIS;

AMINO ACID MOTIFS; ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS; FEMALE; FLUOXETINE; ION CHANNELS; MICE; MUTAGENESIS, SITE-DIRECTED; OOCYTES; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; PROPOXYPHENE; SODIUM; TRANSCRIPTION, GENETIC; XENOPUS LAEVIS;

EID: 0037401021     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00831-3     Document Type: Article

References (42)

1. + channels. Ann NY Acad Sci. 868:1999;233-285.
2. + conduction and selectivity. Science. 280:1998;69-77.
3. + channel selectivity filter by mutant cycle-based structure analysis. Neuron. 16:1996;131-139.
4. Chapman M.L., Krovetz H.S., VanDongen A.M. GYGD pore motifs in neighbouring potassium channel subunits interact to determine ion selectivity. J Physiol. 530:2001;21-33.
5. Kirsch G.E., Pascual J.M., Shieh C.C. Functional role of a conserved aspartate in the external mouth of voltage-gated potassium channels. Biophys J. 68:1995;1804-1813.
6. + channel pore. J Biol Chem. 272:1997;1011-1018.
7. + channel-related long-QT syndrome: altered gating and selectivity in the HERG1 N629D mutant. Circ Res. 86:2000;507-513.
8. Lesage F., Lazdunski M. Molecular and functional properties of two-pore-domain potassium channels. Am J Physiol Renal Physiol. 279:2000;F793-F801.
9. Ketchum K.A., Joiner W.J., Sellers A.J., Kaczmarek L.K., Goldstein S.A. A new family of outwardly rectifying potassium channel proteins with two pore domains in tandem. Nature. 376:1995;690-695.
10. + channels closely related to TASK-1. J Neurophysiol. 86:2001;130-142.
11. + channel. J Biol Chem. 275:2000;28722-28730.
12. + channel. FEBS Lett. 471:2000;137-140.
13. + channel from human kidney. J Biol Chem. 273:1998;30863-30869.
14. Salinas M., Reyes R., Lesage F., et al. Cloning of a new mouse two-P domain channel subunit and a human homologue with a unique pore structure. J Biol Chem. 274:1999;11751-11760.
15. + channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J. 17:1998;3297-3308.
16. + channels TREK-1 and TRAAK. J Biol Chem. 275:2000;10128-10133.
17. Maingret F., Patel A.J., Lesage F., Lazdunski M., Honore E. Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J Biol Chem. 274:1999;26691-26696.
18. + channels. Nat Neurosci. 2:1999;422-426.
19. + channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi and Gq protein-coupled receptors. J Biol Chem. 275:2000;28398-28405.
20. Lopes C.M., Zilberberg N., Goldstein S.A. Block of Kcnk3 by protons. Evidence that 2-P-domain potassium channel subunits function as homodimers. J Biol Chem. 276:2001;24449-24452.
21. + channels TREK-1 and TRAAK. Mol Pharmacol. 57:2000;906-912.
22. + channels TREK-1 and TRAAK. Brain Res. 892:2001;94-101.
23. + channel is a molecular substrate for neuronal effects of inhalation anesthetics. J Neurosci. 20:2000;6347-6354.
24. + channel, is modulated by multiple neurotransmitters in motoneurons. Neuron. 25:2000;399-410.
25. + channel to sense external pH variations near physiological pH. EMBO J. 16:1997;5464-5471.
26. + channel subunits via a disulfide bridge. EMBO J. 15:1996;6400-6407.
27. Czirjak G., Enyedi P. Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits. J Biol Chem. 277:2002;5426-5432.
28. + channel (cTBAK-1). Circ Res. 82:1998;513-518.
29. + channels. Biochem Biophys Res Commun. 282:2001;249-256.
30. + channel subunits: kinetic properties and expression in rat heart. Am J Physiol. 277:1999;H1669-H1678.
31. + channel TASK-1. EMBO J. 20:2001;47-54.
32. Ulens C., Daenens P., Tytgat J. Norpropoxyphene-induced cardiotoxicity is associated with changes in ion-selectivity and gating of HERG currents. Cardiovasc Res. 44:1999;568-578.
33. Fuller R.W., Wong D.T. Inhibition of serotonin reuptake. Fed Proc. 36:1977;2154-2158.
34. Choi J.S., Hahn S.J., Rhie D.J., Yoon S.H., Jo Y.H., Kim M.S. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther. 291:1999;1-6.
35. Yeung S.Y., Millar J.A., Mathie A. Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine. Br J Pharmacol. 128:1999;1609-1615.
36. Deak F., Lasztoczi B., Pacher P., Petheo G.L., Valeria K., Spat A. Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology. 39:2000;1029-1036.
37. Maertens C., Wei L., Voets T., Droogmans G., Nilius B. Block by fluoxetine of volume-regulated anion channels. Br J Pharmacol. 126:1999;508-514.
38. Tytgat J., Maertens C., Daenens P. Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1). Br J Pharmacol. 122:1997;1417-1424.
39. + channel determined by construction of multimeric cDNAs. Neuron. 9:1992;861-871.
40. Tanaka A., Tokimasa T. Theoretical background for inward rectification. Tokai J Exp Clin Med. 24:1999;147-153.
41. Holland D.R., Steinberg M.I. Electrophysiologic properties of propoxyphene and norpropoxyphene in canine cardiac conducting tissues in vitro and in vivo. Toxicol Appl Pharmacol. 47:1979;123-133.
42. + current in squid giant fiber lobe neuron. J Gen Physiol. 107:1996;243-260.